2m 2m 2m 2m 2m 2m 2m
ImageneBio (IMA)
NASDAQ
$5.52+$0.07 (+1.30%)
Price as of Jun 03, 2026 4:17 PM EDT- $66.3MMarket Cap
- -79.57%1-Year Change
- BiotechnologyIndustry
ImageneBio (IMA)
$5.52+$0.07 (+1.30%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 800,000 -91.27% | 9.2M 0.00% | 9.2M -41.35% | 15.6M -49.59% | |
Cost of Revenue | N/A N/A | 100,000 0.00% | 100,000 N/A | N/A N/A | |
Gross Profit | 800,000 -91.17% | 9.1M 0.00% | 9.1M -41.99% | 15.6M -49.59% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -28.5M -7.61% | -30.9M -48.24% | -59.7M -7.26% | -64.3M +36.54% | |
Depreciation and Amortization Expense | 399,000 -18.57% | 490,000 -51.96% | 1.0M +35.82% | 751,000 +38.05% | |
Total Operating Expenses | 49.3M -16.49% | 59.0M -30.27% | 84.6M -2.25% | 86.5M +32.86% | |
Operating Profit | -48.5M -17.84% | -59.0M -21.80% | -75.4M +6.36% | -70.9M +107.70% | |
Interest Income | N/A N/A | N/A N/A | 7.1M +230.90% | 2.1M N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 -100.00% | 7.1M +230.90% | 2.1M N/A | |
Total Nonoperating Income and Expense | 2.8M -72.18% | 9.9M +39.53% | 7.1M +231.42% | 2.1M +9,200.00% | |
Income before Taxes | -45.7M -6.89% | -49.1M -28.17% | -68.3M -3.63% | -70.9M +107.70% | |
Income Taxes | -350,000 -330.26% | 152,000 +193.83% | -162,000 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -45.3M -7.89% | -49.2M -27.77% | -68.2M -0.87% | -68.8M +101.57% | |
Net Income from Continuing Operations Applicable to Common | -52.4M +6.75% | -49.1M -28.17% | -68.3M -0.64% | -68.8M +101.57% | |
Basic EPS and Net Income | -9.64 +845.10% | -1.02 -37.42% | -1.63 -14.21% | -1.90 +55.74% | |
Diluted EPS and Net Income | -9.64 +845.10% | -1.02 -37.42% | -1.63 -14.21% | -1.90 +55.74% | |
Basic Weighted Average Shares | 4.9M -89.91% | 48.3M +15.63% | 41.7M +15.33% | 36.2M +29.32% | |
Diluted Weighted Average Shares | 4.9M -89.91% | 48.3M +15.63% | 41.7M +15.33% | 36.2M +29.32% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 94.5M +139.97% | 39.4M -67.14% | 119.9M +100.09% | 59.9M -74.20% | |
Short-Term Investments | 40.8M -51.98% | 85.0M +52.94% | 55.6M -42.73% | 97.0M N/A | |
Cash and Cash Equivalents and Short-Term Investments | 135.3M +8.81% | 124.4M -29.11% | 175.5M +11.80% | 156.9M -32.41% | |
Total Current Assets | 140.3M +10.32% | 127.2M -28.82% | 178.7M +11.66% | 160.0M -32.35% | |
Accumulated Depreciation | 0 -100.00% | 1.4M -47.20% | 2.7M +49.97% | 1.8M +69.93% | |
Property and Plant and Equipment and Net | 0 -100.00% | 593,000 -74.60% | 2.3M -27.15% | 3.2M +31.41% | |
Total Long-Term Assets | 4.9M +722.60% | 593,000 -74.60% | 2.3M -27.15% | 3.2M +31.41% | |
Total Assets | 153.0M +8.10% | 141.5M -26.33% | 192.1M +11.51% | 172.3M -30.51% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 0 N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 11.2M +4.23% | 10.8M -24.13% | 14.2M -33.94% | 21.5M -20.91% | |
Total Long-Term Debt | N/A N/A | 1.1M +11.68% | 950,000 N/A | N/A N/A | |
Total Long-Term Liabilities | 870,000 -76.72% | 3.7M -47.95% | 7.2M -37.37% | 11.5M -10.52% | |
Total Liabilities | 19.8M +27.36% | 15.6M -30.26% | 22.3M -11.68% | 25.3M -36.78% | |
Retained Earnings | -230.1M -30.63% | -331.6M +17.44% | -282.4M +31.82% | -214.2M +47.28% | |
Total Stockholders Equity | 133.1M +5.72% | 125.9M -25.82% | 169.8M +15.51% | 147.0M -29.30% | |
Total Shares Outstanding | 10.7M -77.93% | 48.3M 0.00% | 48.3M +33.10% | 36.3M +0.79% | |
Cash Flow | |||||
Cash from Operating Activities | -47.8M +4.00% | -46.0M -42.31% | -79.7M +7.60% | -74.1M +23.00% | |
Capital Expenditures | N/A N/A | 414,000 0.00% | 414,000 -71.07% | 1.4M -18.69% | |
Cash from Investing Activities | -5.8M -83.34% | -34.9M -154.41% | 64.1M +164.61% | -99.3M +5,541.14% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 135.5M +78.29% | 76.0M 0.00% | 76.0M +6,838.81% | 1.1M -99.17% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | 98.91% 0.00% | 98.91% N/A | N/A N/A | |
Operating Margin | -6,056.37% +840.71% | -643.81% -21.80% | -823.33% +81.35% | -453.99% N/A | |
Return on Assets | -30.80% +4.34% | -29.52% -21.12% | -37.42% +14.31% | -32.73% N/A | |
Return on Equity | -35.01% +5.13% | -33.30% -22.64% | -43.04% +11.06% | -38.76% N/A | |
Revenue Growth | -91.27% N/A | 0.00% +100.00% | -41.35% -16.63% | -49.59% N/A | |
Current Ratio | 12.49 +5.84% | 11.80 -6.19% | 12.58 +69.02% | 7.44 N/A | |
Cash Ratio | 8.41 +130.23% | 3.65 -56.70% | 8.44 +202.90% | 2.79 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow